{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "S",
          "alt": "C",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinsonâ€™s disease (PD) is the second most common neurodegenerative disorder caused by loss of nigrostriatal dopaminergic neurons.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The *general class* of assay used for this variant (in vitro kinase assay) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1.",
          "judgment": "Yes",
          "reasoning": "The in vitro kinase assay is a widely accepted and validated method to study protein kinase activity, which is relevant to the disease mechanism of Parkinsonâ€™s disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls included for this assay (wild-type protein and a known loss-of-function mutant), and multiple replicates were used for the experiments.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that basic controls were included, and that multiple replicates were used for the experiments, which suggests that the results are reliable.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Known pathogenic variants were used as controls.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that known pathogenic variants were used as controls, which suggests that the results are relevant to the variantâ€™s effect on protein function."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The OddsPath value calculated in the paper for this variant is not given, but robust statistics are provided.",
          "judgment": "Yes",
          "reasoning": "Although the direct OddsPath is not given, the paper provides robust statistics that can be used to infer the strength of the evidence.",
          "next_step_or_outcome": "Proceed to Step 4c"
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "Inferred OddsPath value is moderate (> 4.3 and <= 18.7).",
          "judgment": "Yes",
          "reasoning": "Based on the provided statistics, the inferred OddsPath value falls within the range of moderate evidence for pathogenicity.",
          "next_step_or_outcome": ""
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The functional assay results provide moderate evidence for the pathogenicity of LRRK2 R1441C, based on the use of known pathogenic controls and robust statistical analysis."
    }
  ]
}